it was set to drop 16.5٪ because that's what it's being diluted...

it was set to drop 16.5٪ because that's what it's being diluted by.

The big test is going to be the 105 phase 2 results that they're getting next month(?). Im not confident that they're going to be positive.

you'd have to think that a negative result would halve the share price?

That puts us below the capital raise price.

Also it looks like demad has dropped right off. Because Angermeyer has covered the raise @ $0.06 there's going to be a bunch of shenanigans over the next few weeks.

More pain for shareholders.

glta